Fairmount Funds Management LLC

13F Holdings History for Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA)

Symbol: ORKA on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 11.2M shares
Security Ownership: 20%

Shares, Excluding Options vs Price

Value, Excluding Options

Fairmount Funds Management LLC ownership in Oruka Therapeutics, Inc. Common Stock, par value $0.001 per share (ORKA)

2025-09-19 - Fairmount Funds Management LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 11.2M shares of Oruka Therapeutics, Inc. Common Stock, par value $0.001 per share (ORKA). This represents 20% percent ownership of the company. In their previous filing dated 2025-03-10, Fairmount Funds Management LLC had reported owning 8.51M shares, indicating an increase of 31.1% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Fairmount Funds Management LLC	19.99%		$162M	11.2M	+2,650,917	+31.1%	$14.51	13D/A	9/17/2025	19 Sep 2025 18:56:13
Fairmount Funds Management LLC	19.99%		$80.2M	8.51M			$9.42	13D/A	3/6/2025	10 Mar 2025 19:00:37

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	6.41%	+0.58%	$71.3M	3.71M	+333,340	+9.89%	$19.23	Q3 2025
6/30/2025	4.9%		$37.8M	3.37M			$11.21	Q2 2025
3/31/2025	5.37%		$34.6M	3.37M			$10.26	Q1 2025
12/31/2024	6.5%	+0.31%	$65.4M	3.37M	+160,000	+4.98%	$19.39	Q4 2024
9/30/2024	6.38%	+6.38%	$78.7M	3.21M	+3,211,922	NEW	$24.51	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.